<SEC-DOCUMENT>0001178913-23-002136.txt : 20230605
<SEC-HEADER>0001178913-23-002136.hdr.sgml : 20230605
<ACCEPTANCE-DATETIME>20230605070022
ACCESSION NUMBER:		0001178913-23-002136
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20230601
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230605
DATE AS OF CHANGE:		20230605

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813676773
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38807
		FILM NUMBER:		23991199

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>zk2329839.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:cef="http://xbrl.sec.gov/cef/2022" xmlns:cmmb="http://chemomab.com/20230601" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 23.1.1.5115
         Copyright 1995 - 2023 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_c4648d413a80429490b83737684960a3" contextRef="c20230601to20230601" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_827b499388894d2983d2699b4fac3458" contextRef="c20230601to20230601">00-0000000</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_bb5eac91d82c47d694f161e9a8eda0ed" contextRef="c20230601to20230601">0001534248</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_7800ee96276548b596341b580ba682e4" contextRef="c20230601to20230601_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">NASDAQ</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_6d5d9dde38ce41a79ef18960f5e679b6" contextRef="c20230601to20230601_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">NASDAQ</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="cmmb-20230601.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20230601to20230601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230601to20230601_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230601to20230601_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-01</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div> <div><br /></div>

      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b> UNITED STATES</b></p>
      <p style="font: 14pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>WASHINGTON, D.C. 20549</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;&#160;</p>
      <p style="font: 14pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_1e8d67a5e319479a96041d8c4f7e3915" contextRef="c20230601to20230601">8-K</ix:nonNumeric></b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>CURRENT REPORT</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>Pursuant to Section&#160;13 or 15(d)</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>of the Securities Exchange Act of 1934</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_097c3bd6996d46e2bd4575c8433d9ffd" contextRef="c20230601to20230601" format="ixt:date-monthname-day-year-en">June 1, 2023</ix:nonNumeric></b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
      <p style="font: 16pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_54f7699f403b4b8da0f3061dbb621ab8" contextRef="c20230601to20230601">Chemomab Therapeutics Ltd.</ix:nonNumeric><br />
        </b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>(Exact name of Registrant as Specified in Its Charter)</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" border="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr style="vertical-align: top;">

    <td style="width: 33%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">State of <ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_ed7f83e55f0a4b08beddae26671ea988" contextRef="c20230601to20230601" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric></td>

    <td style="width: 33%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_23f534d54203453daaea000a94b759db" contextRef="c20230601to20230601">001-38807</ix:nonNumeric><br />
            </td>

    <td style="width: 33%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_827b499388894d2983d2699b4fac3458">81-3676773</span><br />
            </td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>(State or Other Jurisdiction</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>(Commission</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>(IRS Employer</b></td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>of Incorporation)</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>File Number)</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>Identification No.)</b></td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" border="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr>

    <td style="width: 50%; text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_e24b9d3f80794d4685c212a8f19bc425" contextRef="c20230601to20230601">Kiryat Atidim, Building 7</ix:nonNumeric></span><br />
            </td>

    <td style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_4fa2b9620e824a57b1f54dd90922a682" contextRef="c20230601to20230601">Tel Aviv</ix:nonNumeric>,
                <ix:nonNumeric name="dei:EntityAddressCountry" id="Fact_b9d79dd8c8ac402da729318d023d8bec" contextRef="c20230601to20230601" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></b></td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_7d3c117f227b4ad7b829a6bd78c06980" contextRef="c20230601to20230601">6158002</ix:nonNumeric><br />
              </b></td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b>(Address of principal executive offices)</b></td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b>(Zip Code)</b></td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;"><b>Registrant&#8217;s telephone number, including area code: +<ix:nonNumeric name="dei:CityAreaCode" id="Fact_056db533a90749b29f8b400205334538" contextRef="c20230601to20230601">972</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_a465d30b3ba54a55af9eec32f997a7b4" contextRef="c20230601to20230601">77-331-0156</ix:nonNumeric></b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;"><b>(Former name or former address, if changed since last report)</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr style="vertical-align: top;">

    <td style="width: 5%; text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_58591e2e1f2443529562a6b7d3838234" contextRef="c20230601to20230601" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: 95%; text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_34813f63dc0844ef81c013044741f24c" contextRef="c20230601to20230601" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_c93b00f1407c48d2abcfa1faa8eb2967" contextRef="c20230601to20230601" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_ee53ffb1d4404dd9bf8384d2237b75eb" contextRef="c20230601to20230601" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;"><b>Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" border="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr style="vertical-align: bottom;">

    <td style="width: 49%; text-align: center; white-space: nowrap; font-family: 'Times New Roman',Times,serif; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><b>Title of each class</b></td>

    <td style="width: 1%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 24%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><b>Trading<br />
                Symbol(s)</b></td>

    <td style="width: 1%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 25%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><b>Name of each <br />
                exchange<br />
                on&#160;which&#160;registered</b></td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 49%; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_b123c56576e3485d98bde4754511ff63" contextRef="c20230601to20230601_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share</ix:nonNumeric><br />
            </td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 24%; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_efc8b1a62843452ea835025b22e31abb" contextRef="c20230601to20230601_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">CMMB</ix:nonNumeric><br />
            </td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 25%; font-weight: bold;"><span style="-sec-ix-hidden:Fact_6d5d9dde38ce41a79ef18960f5e679b6">Nasdaq Capital Market</span><br />
            </td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 49%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 24%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 25%; font-weight: bold;">&#160;</td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 49%; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_adcba5d2ba7c41fa96ede1c9ee9b9160" contextRef="c20230601to20230601_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">Ordinary shares, no par value per share</ix:nonNumeric><br />
            </td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 24%; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_e57ed6f5b2144c9b95a26c319b8d02b2" contextRef="c20230601to20230601_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">N/A</ix:nonNumeric></td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 25%; font-weight: bold;"><span style="-sec-ix-hidden:Fact_7800ee96276548b596341b580ba682e4">Nasdaq Capital Market</span>*</td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">* Not for trading; only in connection with the registration of American Depositary Shares.</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule&#160;12b-2 of the
        Securities Exchange Act of 1934 (&#167;&#160;240.12b-2 of this chapter).</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">Emerging growth company&#160; <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_dd30d57e27ef4063b7ff9d2b9c5d7da4" contextRef="c20230601to20230601" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
        accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160; <ix:nonNumeric name="dei:EntityExTransitionPeriod" id="Fact_4060debb196f400b9b60e23eaa2c782f" contextRef="c20230601to20230601" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></p>
    </div>

    <div> <span style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><br />
      </span></div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--PROfilePageNumberReset%Num%2%- % -%-->
    <div style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
      <div>
        <div class="BRPFPageHeader">
          <div style="line-height: 1.25;"><br />
          </div>

          <div style="line-height: 1.25;">
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 7%; vertical-align: top;">
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">
                      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Item
                          5.02</span> <br />
                      </div>
                    </div>
                  </td>

    <td style="width: 93%; vertical-align: top;">
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Departure


                        of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div>
                  </td>

  </tr>


</table>
            <div style="line-height: 1.25;"><br />
            </div>

          </div>

        </div>

        <div style="line-height: 1.25;">
          <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-decoration: underline;">Appointment of Dr. Adi Mor as Chief Executive Officer to Replace Dr. Dale Pfost</span></div>

        </div>

        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br />
          </div>

          <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On June 1, 2023, the board of directors (the &#8220;Board&#8221;) of Chemomab Therapeutics Ltd. (the &#8220;Company&#8221; or &#8220;Chemomab&#8221;)
            appointed Dr. Adi Mor, co-founder of the Company, a current class III member of the Board and the Company&#8217;s Chief Scientific Officer, as Chief Executive Officer of the Company to replace Dr. Dale Pfost, effective as of the same date.</div>

          <div style="line-height: 1.25;"><br />
          </div>

          <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Below is certain biographical information about Dr. Mor:</div>

          <div style="line-height: 1.25;"><br />
          </div>

          <div style="line-height: 1.25;">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">Dr. Adi Mor</span> is the
              co-founder of Chemomab Ltd., the wholly-owned subsidiary of the Company, and served as Chemomab Ltd.&#8217;s Chief Executive Officer, Chief Scientific Officer and a member of Chemomab Ltd.&#8217;s board of directors from its formation in 2011 until the
              Chemomab Ltd. - Anchiano Therapeutics Ltd. merger that was consummated on March 16, 2021 (the &#8220;Merger&#8221;). Dr. Mor previously served as Chief Executive Officer of the Company through October 25, 2021. Dr. Mor has in-depth knowledge in
              immunology focusing on rare diseases and broad experience in designing, developing and patenting a novel class of monoclonal antibodies to treat inflammatory and fibrotic diseases. Dr. Mor received her Ph.D. in immunology from Tel Aviv
              University in the Department of Neurobiochemistry in Israel and is the lead author of numerous scientific journal publications regarding immunology and inflammatory disorders.</div>

          </div>

          <div style="line-height: 1.25;"><br />
          </div>

          <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Board, upon the recommendation of the compensation committee, will decide Dr. Mor's compensation in connection
            with her new role as Chief Executive Officer on a future date, which compensation will be subject to shareholder approval under the Israeli Companies Law, 5759-1999 (the &#8220;Companies Law&#8221;). The Company will disclose such compensation in a
            subsequent SEC report.</div>

          <div style="line-height: 1.25;"><br />
          </div>

          <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In connection with his replacement as Chief Executive Officer, on June 1, 2023, Dr. Dale Pfost agreed to step down
            from his position on the Board, including in his capacity as Chairman of the Board, effective as of the same date (the &#8220;Pfost Effective Date&#8221;). The foregoing decision was not due to any disagreements on any matter relating to the Company&#8217;s
            operations, policies or practices.</div>

          <div style="line-height: 1.25;"><br />
          </div>

          <div style="line-height: 1.25;">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In connection with Dr. Pfost being replaced by Dr. Mor, subject to his execution&#160;of an effective separation and release
              agreement (the &#8220;Pfost Separation Agreement&#8221;) and compliance with certain restrictive covenants set forth in the Pfost Separation Agreement, Dr. Pfost will be entitled to receive the following severance payments and benefits under his
              employment agreement with Chemomab Therapeutics, Inc., the wholly-owned subsidiary of the Company (the &#8220;US Subsidiary&#8221;), dated September 1, 2021 (the &#8220;Pfost Employment Agreement&#8221;):</div>

            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

          </div>

        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 3%; vertical-align: middle;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 3.05%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
              </td>

    <td style="width: 94%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">An amount in cash equal to Dr. Pfost&#8217;s base salary for a period of 12 (twelve) months following the Pfost Effective Date;</div>
              </td>

  </tr>


</table>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br />
          </div>

        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 3%; vertical-align: middle;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 3.05%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
              </td>

    <td style="width: 94%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Acceleration of vesting of all time-based stock option awards granted to Dr. Pfost under the Company&#8217;s 2015 Share Incentive
                    Plan (the &#8220;Plan&#8221;); and</div>
                </div>
              </td>

  </tr>


</table>
        <div style="line-height: 1.25;">
          <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 3%; vertical-align: middle;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 3.05%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
              </td>

    <td style="width: 94%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Payment of an amount equal to the full premium cost of Dr. Pfost&#8217;s participation in the COBRA plan during the twelve (12) month
                  period following the Pfost Effective Date.</div>
              </td>

  </tr>


</table>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br />
          </div>

          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">- 2 -</span></div>

            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          </div>

        </div>

        <div style="line-height: 1.25;">
          <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-decoration: underline;">Appointment of Ms. Sigal Fattal as Chief Financial Officer to Replace Mr. Donald Marvin</span></div>

        </div>

        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br />
          </div>

          <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On June 1, 2023, the Board appointed Ms. Sigal Fattal, the VP of Finance of the Company, as the Chief Financial
            Officer of the Company to replace Mr. Donald Marvin, effective as of the same date.</div>

          <div style="line-height: 1.25;"><br />
          </div>

          <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Below is certain biographical information about Ms. Fattal:</div>

          <div style="line-height: 1.25;"><br />
          </div>

          <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">Sigal Fattal</span>
            previously served as Chemomab Ltd.&#8217;s interim Chief Financial Officer from October 2020 until the Merger and continued in that capacity for the Company following the Merger until November 8, 2021, following which she became the Company&#8217;s VP of
            Finance. Prior to joining Chemomab Ltd., from March 2017 to December 2019, Ms. Fattal served as Chief Financial Officer at BiomX (NYSE American: PHGE), a clinical stage microbiome product discovery company. Prior to joining BiomX, Ms. Fattal
            served as Chief Financial Officer at Evogene (Nasdaq and TASE: EVGN), a computational biology company, from 2013 to 2016. Prior to that time, Ms. Fattal served in multiple financial and operational executive roles in various companies. Ms.
            Fattal also currently serves as co-founder of Simbiz, which was started in September 2020 and which offers one-stop-shop corporate services to startup companies. Ms. Fattal is a certified CPA (Isr.), and holds a BA in Accounting and Economics,
            and an MBA, both from Tel Aviv University.</div>

          <div style="line-height: 1.25;"><br />
          </div>

          <div style="line-height: 1.25;">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Board, upon the recommendation of the compensation committee, will decide Ms. Fattal&#8217;s compensation in connection with her
              new role as Chief Financial Officer on a future date, which the Company will disclose in a subsequent SEC report.</div>

            <div style="line-height: 1.25;"><br />
            </div>

            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In connection with Mr. Marvin being replaced by Ms. Fattal, subject to his execution and&#160;non-revocation&#160;of an effective
              separation and release agreement (the &#8220;Marvin Separation Agreement&#8221;) and compliance with certain restrictive covenants set forth in the Marvin Separation Agreement, Mr. Marvin will be entitled to receive the following severance payments and
              benefits under his employment agreement with the US Subsidiary, dated November 8, 2021 (the &#8220;Marvin Employment Agreement&#8221;):</div>

          </div>

          <div style="line-height: 1.25;"><br />
          </div>

        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 3%; vertical-align: middle;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 3.05%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
              </td>

    <td style="width: 94%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">An amount in cash equal to Mr. Marvin&#8217;s base salary for a period of 12 (twelve) months following the Marvin Effective Date;</div>
              </td>

  </tr>


</table>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br />
            </div>

          </div>

        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 3%; vertical-align: middle;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 3.05%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
              </td>

    <td style="width: 94%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
                  <div style="line-height: 1.25;">
                    <div style="line-height: 1.25;">
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Acceleration of vesting of the time-based stock option awards granted to Mr. Marvin under the Plan due to vest on or
                        before December 31, 2023; and</div>
                    </div>
                  </div>
                </div>
              </td>

  </tr>


</table>
        <div style="line-height: 1.25;">
          <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 3%; vertical-align: middle;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 3.05%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
              </td>

    <td style="width: 94%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Payment of an amount equal to the full premium cost of Mr. Marvin&#8217;s participation in the COBRA plan during the twelve (12)
                  month period following the Marvin Effective Date.</div>
              </td>

  </tr>


</table>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br />
          </div>

          <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-decoration: underline;">Appointment of Dr. Nissim Darvish as Chairman of the Board</span></div>

        </div>

        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br />
          </div>

          <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On June 1, 2023, the Board appointed Dr. Nissim Darvish, a class I member of the Board, as Chairman of the Board,
            effective as of the same date. Dr. Darvish also serves as chairman of the compensation committee of the Board and is a member of the corporate governance and nominating committee of the Board.</div>

          <div style="line-height: 1.25;"><br />
          </div>

          <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Below is certain biographical information about Dr. Darvish:</div>

          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;"><br />
            </div>

            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">Nissim Darvish</span>, M.D.,
              Ph.D.&#160;has served on our Board since March 16, 2021. Dr. Darvish is a General Partner at Eliraz ventures, a venture capital fund under formation. Dr. Darvish currently serves as a director of several private companies. Prior to his current
              position, Dr. Darvish served as a Venture Partner at OrbiMed Israel and as a member of the boards of directors of 9 Meters Biopharma Inc. and Medigus Ltd. Previously, Dr. Darvish was employed at Pitango Venture Capital, where he was a General
              Partner managing life sciences investments. He was also the founder and CEO of Impulse Dynamics, where he oversaw a $250 million realization event. Dr. Darvish obtained his M.D. and Ph.D. in Biophysics and Physiology from the Technion in
              Israel, and subsequently conducted his post-doctoral research at NIH. He has published over 100 patents and authored over 20 publications.</div>

          </div>

          <div style="line-height: 1.25;"><br />
          </div>

          <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Board, upon the recommendation of the compensation committee, may determine to provide Dr. Darvish with
            additional compensation in connection with his role as chairman of the Board, which compensation will be subject to shareholder approval under the Companies Law. In the event the Board decides to accord Dr. Darvish additional compensation, the
            Company will disclose such additional compensation in a subsequent SEC report.</div>

        </div>

        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br />
          </div>

          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">- 3 -</span></div>

            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          </div>

        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 7%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item&#160;7.01.</div>
              </td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Regulation FD Disclosure.</div>
              </td>

  </tr>


</table>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br />
          </div>

          <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">A copy of the Company&#8217;s press release announcing changes to the executive team, including the departures of Dr.
            Pfost as Chief Executive Officer and a member of the Board, and Mr. Marvin, as Chief Financial Officer, Executive Vice President and Chief Operating Officer, and the appointment of Dr. Mor as Chief Executive Officer and Sigal Fattal as Chief
            Financial Officer, is attached as Exhibit 99.1 to this Current Report on Form&#160;8-K,&#160;and is incorporated herein by reference.</div>

          <div style="line-height: 1.25;"><br />
          </div>

          <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The information in Item 7.01 to this Current Report on Form&#160;8-K,&#160;including Exhibit 99.1, is being furnished and
            shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any
            filing under the Securities Act of 1933, as amended or the Exchange Act, except as expressly set forth by specific reference in such filing.</div>

          <div style="line-height: 1.25;"><br />
          </div>

        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 7%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item&#160;9.01.</div>
              </td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Financial Statements and Exhibits.</div>
              </td>

  </tr>


</table>
        <div style="line-height: 1.25;">
<div><br /></div>

          <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d) Exhibits.</div>

        </div>

        <div style="line-height: 1.25;">
          <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>

        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 5.87%; vertical-align: bottom; border-bottom: 2px solid #000000; white-space: nowrap;">
                <div style="line-height: 1.25;">
                  <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br />
                    </span>No.</div>
                </div>
              </td>

    <td style="width: 3.09%; vertical-align: bottom;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;&#160;</div>
              </td>

    <td style="width: 91.04%; vertical-align: bottom; border-bottom: 2px solid #000000; white-space: nowrap;">
                <div style="line-height: 1.25;">
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Description</div>
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 5.87%; vertical-align: middle;">&#160;</td>

    <td colspan="2" style="width: 94.13%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 5.87%; vertical-align: middle;">&#160;</td>

    <td colspan="2" style="width: 94.13%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 5.87%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="exhibit_99-1.htm">99.1</a></div>
              </td>

    <td style="width: 3.09%; vertical-align: bottom;"><a href="exhibit_99-1.htm"><br />
                </a></td>

    <td style="width: 91.04%; vertical-align: top; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                <div style="text-align: left; line-height: 1.25;"><a href="exhibit_99-1.htm">Press Release, dated June 5, 2023</a></div>
              </td>

  </tr>

  <tr>

    <td style="width: 5.87%; vertical-align: middle;">&#160;</td>

    <td colspan="2" style="width: 94.13%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 5.87%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">104</div>
              </td>

    <td style="width: 3.09%; vertical-align: bottom;"><br />
              </td>

    <td style="width: 91.04%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)</div>
              </td>

  </tr>


</table>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br />
          </div>

          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">- 4 -</span></div>

            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          </div>

        </div>

        <div style="line-height: 1.25;"><br />
        </div>

        <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

        <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

        <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
          signed on its behalf by the undersigned hereunto duly authorized.</div>

        <div style="text-align: left; line-height: 1.25;"><br />
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: bottom;">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="2" style="vertical-align: bottom;">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">CHEMOMAB THERAPEUTICS LTD.</div>
              </td>

    <td style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: middle;">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 3%; vertical-align: middle;">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 27%; vertical-align: middle;">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 20%; vertical-align: middle;">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Date: June 5, 2023</div>
              </td>

    <td style="width: 3%; vertical-align: top;">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">By:</div>
              </td>

    <td style="width: 27%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">/s/&#160;</span>Dr.
                  Adi Mor</div>
              </td>

    <td style="width: 20%; vertical-align: middle;">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: bottom;">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 3%; vertical-align: bottom;">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 27%; vertical-align: bottom;">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Name: Dr. Adi Mor</div>
              </td>

    <td style="width: 20%; vertical-align: bottom;">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: bottom;">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 3%; vertical-align: bottom;">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 27%; vertical-align: bottom;">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Title: Chief Executive Officer, Chief Scientific Officer and Director</div>
              </td>

    <td style="width: 20%; vertical-align: bottom;">
                <div style="text-align: left; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

  </tr>


</table>
        <div style="line-height: 1.25;"><br />
        </div>

        <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">- 5 -</div>

        <div style="text-align: left; line-height: 1.25;"><img width="575" height="8" src="image00001.jpg" alt="graphic" /></div>

      </div>

    </div>

    <div>
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

  </div>

  <div><span style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> </span></div>

  <div class="BRPFPageNumberArea" style="text-align: center;"><br />
  </div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 23.1.1.5115
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 99.1<br>
        </font></u></div>
    <div style="text-align: left;">
      <div>
        <div class="BRPFPageHeader">
          <div style="text-align: left; line-height: 1.25;"><img width="260" height="73" src="image00002.jpg"></div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">Chemomab Therapeutics Announces Executive Leadership Changes and </div>
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">Provides a Corporate Update</div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;&#9472;Adi Mor, PhD, Co-founder, Board Director and Chief Scientific Officer, Reappointed </div>
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">to CEO Role&#9472;</div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#9472;Sigal Fattal, Vice President Finance, Reappointed as CFO&#9472;</div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#9472;On Track for PSC Phase 2 Topline Data Readout in Latter Part of 2024&#9472;</div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#9472;Implementing Further Reorganization and Efficiency Measures Intended to Extend Cash </div>
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Runway to End of 2024, After Expected PSC Phase 2 Topline Data Readout&#9472;</div>
        </div>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
        <div style="line-height: 1.25;">
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#9472;Nissim Darvish, MD, PhD, Appointed Chairman of the Board&#9472;</div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">TEL AVIV, Israel, June 5, 2023 </font>--
          Chemomab Therapeutics Ltd. (<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #293849;">Nasdaq: CMMB), </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #444444;">a
            clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need</font>, today announced changes to its executive leadership&#160; team and provided
          a corporate update.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Adi Mor, PhD, co-Founder and former Chief Executive Officer (CEO) of Chemomab, and current Director and Chief Scientific Officer, has
          been reappointed to the role of CEO, replacing Dale Pfost, PhD. Sigal Fattal, former Chief Financial Officer (CFO) and current Vice President, Finance, has been reappointed to the role of CFO, replacing Donald Marvin. Current Director Nissim
          Darvish, MD, PhD, has been appointed Chairman of the Board, replacing Dr. Pfost. All the appointments were effective June 1, 2023.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;I am excited to resume my corporate leadership responsibilities and look forward to continued engagement with our key stakeholders,&#8221;
          said Dr. Mor. &#8220;After a comprehensive internal strategic review, we are implementing additional cost-reduction measures expected to extend our existing cash runway from mid-year 2024 to the end of 2024, after the expected topline data readout from
          the Phase 2 primary sclerosing cholangitis (PSC) trial of CM-101, our novel, first-in-class anti-CCL24 antibody. Patient enrollment in the PSC trial is going well and is on track to achieve our projected data analysis timelines. Extensive
          preclinical<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">&#160;</font>studies in animal models and human tissue suggest that CM-101 may have therapeutic potential in systemic sclerosis (SSc); however,
          we are suspending initiation of the Phase 2 SSc trial in order to preserve capital. We plan to revisit the timing of study initiation going forward.&#8221;</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;This transition of executive leadership to the company&#8217;s founding team will focus on maintaining business continuity and ensuring
          clinical plan execution,&#8221; continued Dr. Mor. &#8220;Our organization has been strengthened by the addition of highly qualified U.S. based clinical operations, medical and corporate development professionals who have accelerated our clinical trial
          recruitment and positioned CM-101 to achieve a timely clinical readout, while continuing to build relationships with a broad range of potential partners.&#8221;</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;The novelty and potential of our unique approach to fibro-inflammatory diseases are highlighted by our four presentations at major
          medical meetings in June,&#8221; noted Dr. Mor. &#8220;At the EASL Congress later this month we will be discussing biomarker data from our Phase 2 liver fibrosis trial in non-alcoholic steatohepatitis (NASH) patients, including some exciting new data from
          recently completed secondary analyses. The new results show encouraging improvements in additional inflammatory and fibrogenesis-related biomarkers that are consistent and supplemental to the initial results reported from the trial.<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;"> They also suggest that CM-101-treated patients with more active fibrotic disease tend to show greater improvements than patients with less active disease or
            placebo patients.</font> The consistent improvements in fibro-inflammatory biomarkers seen in the Phase 2 NASH results are encouraging and reinforce that these data may serve as a potential bridge to other anti-fibrotic indications such as PSC,
          providing additional evidence that CM-101 could be a valuable therapy for this debilitating disease that lacks effective treatment options.&#8221;</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;We are delighted to reappoint Adi Mor to the CEO role,&#8221; said Dr. Darvish. &#8220;Adi co-founded Chemomab in 2011 and was its CEO until 2021.
          <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">She led the company&#8217;s growth from discovery stage to Phase 2 clinical trials, as well as its transition to a Nasdaq-traded firm. Adi&#8217;s exceptional corporate leadership
            skills are complemented by her extensive knowledge in autoimmune, inflammatory and fibrotic diseases and broad experience in developing monoclonal antibodies.</font> We are grateful to both Dale and Don for their invaluable contributions to
          strengthening the company&#8217;s infrastructure and helping to advance our clinical programs, and we wish them both continued success in their future endeavors.&#8221;</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Sigal Fattal joined Chemomab in 2020 as its CFO. She has over 20 years of experience in establishing and managing effective
            financial business and strategic activities in a range of industries, including serving as a CFO of public companies. Ms. Fattal holds a BA in Accounting and Economics, with honors, and an MBA, both from Tel Aviv University, and is a Certified
            Public Accountant in Israel.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; line-height: 1.25; color: #444444; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Nissim Darvish has served on the Board of Directors of Chemomab since 2015. He is a General Partner at Eliraz
            Ventures and serves as a director at several private and public companies. Previously, he was a Venture Partner at OrbiMed Israel and a member of the boards of directors of 9 Meters Biopharma and Medigus. Earlier, Dr. Darvish was a General
            Partner managing life sciences investments at Pitango Venture Capital. He was also a founder and CEO of Impulse Dynamics. Dr. Darvish obtained his MD and PhD in biophysics and physiology from the Technion in Israel and subsequently conducted
            post-doctoral research at the U.S. National Institutes of Health.</div>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
          <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">About Chemomab Therapeutics Ltd.</div>
        </div>
        <div style="line-height: 1.25;">
          <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Chemomab is a clinical stage biotechnology company discovering and developing innovative therapeutics for fibro-inflammatory diseases
            with high unmet need. Based on the unique and pivotal role of the chemokine CCL24 in promoting fibrosis and inflammation, Chemomab developed CM-101, a monoclonal antibody designed to neutralize CCL24 activity. In preclinical and clinical
            studies to date, CM-101 appears safe, with the potential to treat multiple severe and life-threatening fibro-inflammatory diseases. Chemomab has reported encouraging results from a Phase 2 liver fibrosis study in NASH patients and an
            investigator study in patients with severe lung injury. A Phase 2 trial in primary sclerosing cholangitis patients is ongoing. For more information on Chemomab, visit <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #0000FF;"><u>chemomab.com</u></font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">.</font></div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
        <div style="line-height: 1.25;">
          <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Forward Looking Statements</div>
        </div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These
          forward-looking statements include, among other things, statements regarding the clinical development pathway for CM-101; the future operations of Chemomab and its ability to successfully initiate and complete clinical trials and achieve
          regulatory milestones; the Company&#8217;s cash position and expectations regarding its ability to achieve the topline data readout from the Phase 2 primary sclerosing cholangitis (PSC) trial of CM-101 with its current cash; the nature, strategy and
          focus of Chemomab; the development and commercial potential and potential benefits of any product candidates of Chemomab; and that the product candidates have the potential to address high unmet needs of patients with serious fibrosis-related
          diseases and conditions. Any statements contained in this communication that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements are based upon Chemomab's current expectations.
          Forward-looking statements involve risks and uncertainties. Because such statements deal with future events and are based on Chemomab's current expectations, they are subject to various risks and uncertainties and actual results, performance or
          achievements of Chemomab could differ materially from those described in or implied by the statements in this presentation, including those found under the caption "Risk Factors" and elsewhere in Chemomab's filings and reports with the SEC.
          Chemomab expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Chemomab's expectations with regard thereto or any change in
          events, conditions or circumstances on which any such statements are based, except as required by law.</div>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
          <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Contacts:</div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Media and Investors:</div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Chemomab Therapeutics:<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
          </font>Barbara Lindheim<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
          </font></div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Consulting Vice President, Investor &amp; </div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Public Relations, Strategic Communications</div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Phone: +1 917-355-9234</div>
        <div style="text-align: left; line-height: 1.25; color: #0000FF; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><u>barbara.lindheim@chemomab.com </u></div>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
          <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Investor Relations:</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
            Irina Koffler<br>
            LifeSci Advisors, LLC<br>
            Phone: +1 917-734-7387<br>
            </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #0000FF;"><u>ir@chemomab.com</u></font></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cmmb-20230601.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.1.1.5115 Broadridge-->
<xs:schema targetNamespace="http://chemomab.com/20230601" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:cmmb="http://chemomab.com/20230601" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20230601_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20230601_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20230601_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://chemomab.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xs:element name="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" id="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OrdinarySharesNoParValuePerShareMember" id="cmmb_OrdinarySharesNoParValuePerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>cmmb-20230601_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.1.1.5115 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://chemomab.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="cmmb-20230601.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://chemomab.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="definition: EntityListingsLineItems to DocumentType" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="definition: EntityListingsLineItems to AmendmentFlag" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="definition: EntityListingsLineItems to DocumentPeriodEndDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="definition: EntityListingsLineItems to EntityRegistrantName" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="definition: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="definition: EntityListingsLineItems to EntityFileNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="definition: EntityListingsLineItems to EntityTaxIdentificationNumber" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine2" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine3" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="definition: EntityListingsLineItems to EntityAddressCityOrTown" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="definition: EntityListingsLineItems to EntityAddressStateOrProvince" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="definition: EntityListingsLineItems to EntityAddressCountry" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="definition: EntityListingsLineItems to EntityAddressPostalZipCode" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="definition: EntityListingsLineItems to CityAreaCode" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="definition: EntityListingsLineItems to LocalPhoneNumber" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="definition: EntityListingsLineItems to WrittenCommunications" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="definition: EntityListingsLineItems to SolicitingMaterial" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementTenderOffer" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="definition: EntityListingsLineItems to NoTradingSymbolFlag" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="definition: EntityListingsLineItems to EntityEmergingGrowthCompany" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="definition: EntityListingsLineItems to EntityExTransitionPeriod" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalYearFocus" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="definition: EntityListingsLineItems to EntityCentralIndexKey" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="definition: EntityListingsLineItems to Security12bTitle" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="definition: EntityListingsLineItems to TradingSymbol" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="definition: EntityListingsLineItems to SecurityExchangeName" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EntityListingsLineItems" xlink:to="EntityListingsTable" xlink:title="definition: EntityListingsLineItems to EntityListingsTable" order="30.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: EntityListingsTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20230601.xsd#cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="definition: ClassOfStockDomain to AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20230601.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="OrdinarySharesNoParValuePerShareMember" xlink:title="OrdinarySharesNoParValuePerShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="OrdinarySharesNoParValuePerShareMember" xlink:title="definition: ClassOfStockDomain to OrdinarySharesNoParValuePerShareMember" order="2.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cmmb-20230601_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.1.1.5115 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockDomain_lbl">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis_lbl">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:label xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US" id="dei_EntityExTransitionPeriod_lbl">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:title="label: EntityExTransitionPeriod to dei_EntityExTransitionPeriod_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsTable_lbl" xml:lang="en-US" id="dei_EntityListingsTable_lbl">Entity Listings [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsTable" xlink:to="dei_EntityListingsTable_lbl" xlink:title="label: EntityListingsTable to dei_EntityListingsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsLineItems_lbl" xml:lang="en-US" id="dei_EntityListingsLineItems_lbl">Entity Listings [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsLineItems" xlink:to="dei_EntityListingsLineItems_lbl" xlink:title="label: EntityListingsLineItems to dei_EntityListingsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20230601.xsd#cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" />
    <link:label xlink:type="resource" xlink:label="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" xml:lang="en-US" id="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:to="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" xlink:title="label: AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember to cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20230601.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="OrdinarySharesNoParValuePerShareMember" xlink:title="OrdinarySharesNoParValuePerShareMember" />
    <link:label xlink:type="resource" xlink:label="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" xml:lang="en-US" id="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1">Ordinary shares, no par value per share [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrdinarySharesNoParValuePerShareMember" xlink:to="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" xlink:title="label: OrdinarySharesNoParValuePerShareMember to cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cmmb-20230601_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.1.1.5115 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://chemomab.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="cmmb-20230601.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://chemomab.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20230601.xsd#cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="presentation: ClassOfStockDomain to AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20230601.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="OrdinarySharesNoParValuePerShareMember" xlink:title="OrdinarySharesNoParValuePerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="OrdinarySharesNoParValuePerShareMember" xlink:title="presentation: ClassOfStockDomain to OrdinarySharesNoParValuePerShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: EntityListingsTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="presentation: EntityListingsLineItems to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="presentation: EntityListingsLineItems to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: EntityListingsLineItems to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityListingsLineItems to EntityRegistrantName" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="presentation: EntityListingsLineItems to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: EntityListingsLineItems to EntityTaxIdentificationNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine2" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine3" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: EntityListingsLineItems to EntityAddressCityOrTown" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: EntityListingsLineItems to EntityAddressStateOrProvince" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="presentation: EntityListingsLineItems to EntityAddressCountry" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: EntityListingsLineItems to EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="presentation: EntityListingsLineItems to CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="presentation: EntityListingsLineItems to LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="presentation: EntityListingsLineItems to WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="presentation: EntityListingsLineItems to SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: EntityListingsLineItems to NoTradingSymbolFlag" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: EntityListingsLineItems to EntityEmergingGrowthCompany" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="presentation: EntityListingsLineItems to EntityExTransitionPeriod" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalYearFocus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityListingsLineItems to EntityCentralIndexKey" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="presentation: EntityListingsLineItems to Security12bTitle" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="presentation: EntityListingsLineItems to TradingSymbol" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="presentation: EntityListingsLineItems to SecurityExchangeName" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="EntityListingsLineItems" xlink:title="presentation: EntityListingsTable to EntityListingsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityListingsTable" xlink:title="presentation: CoverAbstract to EntityListingsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0Y!T$# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
&*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ V #8  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #M T8# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ[GV ->J:7^SY8K&IU?6[B60]5M$5 /Q;=G\A78UAJ.CW^\Q3JSV/-Q\5O'
M((U^;CUBC/\ [+6UIOQS\76;K]L-G?I_%YL.QB/8I@#\C7HS? ;PDR;1<:JI
M_O"=,_JF*YS6/V?76-GT76P[#I#>1XS_ ,#7_P")J?:X:6C7X#Y*JZG3>&?C
M;X>UETM]31])N6X!E;="3_OCI^( ]Z]+1TDC62-E=& 964Y!!Z$&OC?Q!X6U
MKPO=?9]7L);<DX20C*/_ +K#@U[C\!8=2_X1:]N+JZF>Q>?R[6!SE4VCYV7T
M!) QTRIK+$8>$8<\'H73J2;Y9'K-?)GCO5M2B\>Z[''J%VB+>RA569@ -QZ#
M-?6=?('C_P#Y*#K_ /U_2_\ H1HP*O-A7V1[M\$+F>Z\!227$TDS_;9!ND<L
M<;4[FO2:\Q^!'_)/I/\ K^D_]!2O3JYZ_P#%D:4_A04445B6%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %?,_QAU._MOB3?Q07US%&(X<)'*R@?NQV!KZ8KY<^-'_ "4W
M4/\ KE#_ .BUKLP2_>?(QK_">@? &\NKNQUPW-S-.5DAV^:Y;'#],U['7BO[
M//\ QX:]_P!=8?Y/7M59XK^*RJ7P(****YS0**** "BBB@"AK&KVNB:>]Y=M
MA1PJC[SGT%>1ZYXNU/6Y&5I3!:GI!$<#'N?XOQJSXZUA]3\02P*_^CVA,2*#
MQN_B/Y\?@*YBOJ\MR^%*FJDU>3_ XZM1MV6P4Z.62&19(G9'7D,IP1^--HKU
MC$[SPSX_GAE2TUES+ >%N#]Y/][U'OU^M>F AE#*001D$=Z^=Z[;PGXY.EQ+
M8:EODM%XCE7EHQZ$=Q_*O"S'*U)>TH+7JO\ (Z*56VDCU.BJMEJ=CJ40DL[J
M*=2,_(V2/J.H_&K+,JJ68@ =237SCBXNS6IU7%HK&U#Q7HFFJ?.OXG<?\LX3
MO;].GXUP.O\ Q!O-15K?3U:SMSP7S^\8?7^'\/SKLP^7UZ[T5EW9G*I&)N^-
M?&*6D4FF:;+NN6^6:53_ *L=P#_>_E]>GF%%=%X+T=-8\01K,NZW@'G2 ]&Q
MT'YD?AFOIZ5&E@:#:Z:M]SE<G4D;WA/P(MS#'J&KJWEM\T5OTW#L6_PKT6"W
MAM85AMXDBC7HB* !^ J3H/:O!?'7QLOC?S:=X6>.&WB8HU\5#M(1UV \!??!
M)Z\5\S5JU\;4NWI^".GW:2/>JSM5T+3M:A,=[;*[8PL@&'7Z'_(KY=M?BAXT
MM+@3+K]S(<Y*RA74^V"/Y5[E\-?B7%XUBDLKR)+?5H$WLB?<E3IN7/3!/(]Q
M^$2H5:'OQ>W8(U8ST.=UKP3JNF7;+;6\MY;D_))$A8X]"!T/Z5V7@'P]=Z/:
MW-S>IY4MQM"Q'JJC/)]SGI[5V-%;U\TK5J/LI6\V$:48RN@HHHKS34**** "
MBBB@ HHHH *K:A?6^F:?<7]W(([>WC:21SV4#)JS7D7QZ\0-9^'[/0X7P]](
M9)@#_P LTQ@'ZL1_WS6E*'M)J),Y<L;GC/C'Q5>>,/$5QJ=T66,G9;PD\11@
M\+]>Y]2378_"OX9?\)3*-9U=&&CQ/A(\D&Y8=1GLH[GOT]<<)X:T.;Q)XCL=
M(@)#W4H4MC.U>K-^"@G\*^Q-/L+;2].M["SB$5M;QB.-!V KT<35]E%0@<U*
M'.^9DL%O#:V\=O;Q)##&H5(XU"JH'8 =*DHHKRCK"BBB@"KJ.FV6K6,MEJ%M
M%<VTHP\<BY!_^O[U%HNC67A_2+?2].C,=K "$4G)Y))R>_)-7Z*=W:P6UN%?
M('C_ /Y*#K__ %_2_P#H1KZ_KY \?_\ )0=?_P"OZ7_T(UVX#XV<^(V1[C\"
M/^2?2?\ 7])_Z"E>D75W;6,#3W=Q#;PKUDE<(H_$\5X%X-^(5KX'^%C+&J3Z
MK<7LOV> G@#:GSOC^'^9X]2/-M7US6O%>I>?J%S<7MPY^1!DA?95' 'L!5/"
MRJ5)2>B!55&*1]3/\0_!Z3"(^(].+'NLP(_,<5M:?J^FZO$9=-U"UO(QU:WF
M5P/K@\5\<W.A:O9PF:ZTJ^@B'5Y;=U4?B15>ROKO3;M+JQN9;:X0Y66)RK#\
M15/ Q:]V0O;OJC[:HKRKX6?%%O$S+HFM,HU55)AF  %P!U!'9QUXX(^E>JUP
M5*<J<N61O&2DKH***S];UO3_  ]I4VI:G<+!;1=6/))[ #N3Z5*3;LBC0K,U
M'Q'HFD-MU+5[&T?^Y-<*K?D3FOG7QE\8-=\1326^FRR:7IN2%2%L2R#U=QS^
M X^M<+9Z?J&JW#1V-G<WDQY*P1-(W/L 37=#!.UYNQSRKJ]HH^L8_B)X/E?8
MOB/3P0?XI@H_,\5O6>H66HP^=8W<%U%_?@D#K^8-?(D_@?Q7;Q&27PYJ@0=2
M+5SC\A679WVH:/>^=9W-Q9W,9QNB<HP]N/Y53P4&O<D+V[6Z/M>BO$_A]\:&
MN;B'2?%+HKN0D6H !1GL)!T'^\./7UKVRN*I2E3=I&\9J2N@HHKYD^-__)1Y
MO^O:+^1JJ%+VLN6]A5)\BN?3=17%S!:0--<S1PQ+RSR,%4?4FOFWX7^,[/P5
MH/B:_G7S;B0VT=M;@X,CXE_)1W/^(KD-?\3Z[XOU'SM2NI;EV;]U F=B>R(.
MG\_4FMU@I.;5]$9NNK7/J&3XA>#XIA$WB/3BQ[K,&'YCBM?3M9TO5TWZ;J-I
M>*!DFWF5\?7!XKX[GT'6+6$S7&DWT,0ZO);NJC\2*JVMU<65PEQ:3RP3H<I)
M$Y5E/L16KP,6O=D3[=]4?;E%>2_"GXI2>(95T'7'!U(*3;W& // '*D?W@,G
MW /<<\Y\2?C!=S7L^C>&;@P6T1*37L9^>4]PA[+[CD]N.O*L-4<^0U=6/+S'
MMFI>(-&T?C4M5LK-B,A9YU0GZ G)K+B^(7@^:0HOB/3@0<?/,%'YG KY-@M-
M0U6X<V]O=7D['<_EHTC$^IQDT7FEZAIVW[;8W5MN^[Y\+)G\Q74L##9RU,?;
MOL?:5O<P7<"S6TT<T3<J\;!E/T(J6OC7P]XHUCPM?+=Z3>R0-G+QYS'(/1EZ
M'_.*^H? 7C6U\;:"+R-1#=PD1W4 .=C>H_V3U'XCM7-7PTJ6NZ-:=53T.IHH
MHKF-0HKEO&GCO2?!-@);UC-=R#]Q:1GYY/<_W5]_YU\Z^*/B5XE\4RR+/>O:
MV;'Y;2V8H@'H>[?C^E=%'#3JZ[(SG543Z<OO%?A[3)#'?:WI]O(#@I)<H&_+
M.:H0_$/P?.^U/$>G@_[<P0?FV*^2;:SN;V7RK6VFGD_NQ(6/Y"K<^@ZS:Q&6
MXTF_AC'5I+9U _$BNKZE!:.1C[>78^RK2^M-0A\ZRNH+F(_QPR!U_,5/7Q/8
M:E?:5=+=:?=SVLZ])(9"A_2O9/ WQOE\V/3_ !7M9&^5=01<%?\ KHH[>X_+
MO657!2BKQU+C73T9[I138Y$FB26)U>-U#*RG(8'H0?2G5Q&X45X=^T1_S+?_
M &]?^TJXGX3ZY9>&_$U[JM^^VWM]/E) ZL=R */<GBNJ.%<J7M$_D8NK:7*?
M4S,J(SNP55&22< "N=NO'WA*RD,<_B'3@X."$G#X/OMS7S9XQ^(.M^,KM_M4
M[06.[]U91,1&H[9_O'W/X8K$_P"$?UKR//\ [(O_ "<9\S[,^W'UQ6T,$K7F
MR77_ )4?7NF^)-#UA_+TW5[&[D_N0W"LWY YK4KX?5GCD#*61U.01P017LGP
MP^+5Y'J%OH7B.Y-Q;S,(X+R4Y>-CT5S_ ! ^IY&?3I-7!.*O%W'"NF[,]\JI
M?ZKIVE1B34;^UM$/1KB98P?S->7?%'XK/H$[Z%H+H=0 _P!(N<;A!G^%1T+?
MR^O3P6274M<U!I)&NK^\E.23NDD;^9J:.$E-<TG9#G6479'U?_PL7P=YOE_\
M)'I^[U\T8_/I6]9:E8ZG#YUA>V]W%_?@E61?S!KXTNM%U6QB\V[TR]MX_P"_
M+;L@_,BFZ9JNH:->I>:;=S6MPG1XFP?H?4>QXK9X&+7NR(5=]4?:U%>>?##X
MCKXSLWLK\)%K%LNYPO"S)TWJ.QZ9'N/7 ]#K@G"4)<LCHC)25T%%%<GX^\<V
M?@C1A<2*)KZ?*VMOG[Y'5CZ*.,_4#O2C%R=D#:2NS7UWQ'I'AJQ^UZO?16T7
M10QRSGT51R3]*\DUO]H$!VCT+1PRCI->OU_X O\ \57CVMZ[J7B+4Y-0U2Z>
MXN).[=%'HHZ >PKJ_"GPE\1^*(4NC&FGV+C*SW((+CU5.I^IP/>O1CA:5./-
M59S.K*3M$NR?'+QB[EE>PC']U;?@?F2:MV'QZ\3V[C[9::?=Q]_W;1M^!!Q^
ME=9;?L^:0L0%UK=]+)W:*-$'Y'=_.JVH_L]VQC)TS794D'1;F$,#^*XQ^1H]
MIA7I;\ Y:IT?A?XT>'=>DCMKX/I5V_ $[ Q$^@DX_4"O1)I?*MI)@ VU"PYZ
MX&:^1/%'@;7_  A*!JEGB!FVI<Q'?$Y_WNQ]B :Z_P"&GQ-GT@'P_K$YDTV9
M#'!+(W-NQ' S_</3VZ],UG5PL6N>EL5"J[VF;'_#0UW_ -"Y#_X%'_XFO:=#
MU$ZOH&FZFT8B:\M8K@Q@YV[U#8SWQFOBROL;P7_R(GA[_L&6W_HI:,71A3BG
M%!1G*3=S<KY<^-'_ "4W4/\ KE#_ .BUKZCKY<^-'_)3=0_ZY0_^BUJ,#_$^
M15?X3N?V>?\ CPU[_KK#_)Z]JKP'X->(-.\,>&/$FJ:G-Y<$<D( '+2-A\*H
M[D_YX%<IXQ^*>O\ BN66&.=[#3"<+:P-C</]MARWTZ>U74P\JM:5MB8U%""/
MH_4/%WAS2I&COM<T^"1>L;7"[Q_P'.:K6WC[PC=L%B\1:;N)P \ZID_\"Q7R
M79Z7J&H9^Q6-U<XZ^3"SX_(4EYIE_I^W[;8W-MNZ>=$R9_,5?U&&W-J3[>78
M^U8IHIXEEAD22-AE71@0?H13Z^--"\4:UX:N1/I&HS6QSED5LH_^\IX/XBOH
MCX=?%&T\9+]@O4CM-81<^6#\DX'4IGN.Z_CSSCGK865-76J-85E+0]#HHHKE
M-3YZN)&EN99'SN=RQSZDU'6GXBL&TSQ!>VK+A5E+)[J>1^AK,K[^G)2@I1V9
MYS5F%%%%6(***TM&T*_UVZ\BRBSM^_(W"(/<_P!.M3.<81YI.R&DWHC-!(((
M.".A%.:1WQO=FQTR<UZ7:?#"R6,?;;^XDDQSY(5 /S!J:3X9:25_=WEZK>K,
MK?\ LHKS7F^$OO\ @:^QF>645W-_\,[Z%2UC>17./X''EL?IU'\JX^^T^\TV
M?R+VWD@D]'&,_0]_PKLHXJC7_ARN9RA*.Z*U>B_"Z-=NIR_Q9C7Z#YO\_A7G
M5=M\-=06WUFXLW8#[5&"ONRY./R+?E6&9Q<L)-+^M2J3M-'7_$"[FLO &N3P
M,4D%HZAAU&1C(]^:^0:^V-3T^#5M*N].N03!=0M"^.N&&#CWYKY!\4>&-1\)
MZU+INHQ,I4GRI=I"3)V93Z?RZ5\]@9*SCU-<0GHS%KJ?AO=S6?Q%T*2!B&>Z
M6)L=U?Y6_0FN6KUSX*^![J]UR+Q+>P-'86F3;%QCSI",9'JJY)SZX]ZZZTE&
MFVS&";DK'T-1117A'>%%%% !1110 4444 %%%% !7S)\;[]KOXC36Y.19VT4
M('ID;_\ V>OINOE#XL;_ /A9^M[]V?,C^]Z>6F/TQ79@5^\?H8U_A.I^ &F+
M<>)]2U)UW?9+8(AQ]UI&Z_7"L/Q-?0U>)?L\;/LWB#&/,WV^?IB3']:]MJ,6
M[UF.BO<04445S&H4444 %%%% !7R!X__ .2@Z_\ ]?TO_H1KZ_KY \?_ /)0
M=?\ ^OZ7_P!"-=V ^-G/B-D+X(\(W7C3Q%%IL#F*%1YEQ/C(CC'7\3T ]37U
M-X>\+Z/X7LEM=)LHX1C#R8S))[LW4UYU\ -.CA\+ZEJ6W]]<7?E9_P!A%!'Z
MNU>NU&+JN4W'HBJ,$HW"O(/BO\,+&ZTFX\0:););7ELIDN((5PLR#EC@=&')
MXZ\]Z]?I'19$9'4,K#!!'!%84ZDJ<N9&DHJ2LSXGT^^N-,U&WO[20QW%O(LD
M;#L0<U]F:1J,>KZ-8ZE#Q'=0),H]-P!Q^M?&>H0+:ZG=6Z9V13.BY] 2*^I?
MA+,T_P +]$=NH21/P65U'Z"N_'13BI'/0>K1VE?+7Q5\;R>+/$DEM;2DZ38N
M8[=5/$C#AI#ZY[>WU->^_$767T'P#J][$Q6;R?*B(ZAG(0$>XW9_"ODFW@DN
M;F*WB&9)7"*/4DX%1@::UFRJ\OLGHOPO^&3>,)3J>IEXM'A?;A3AKAA_"#V4
M=S^ ]1]':;I=AH]DEGIUI#:VZ=(XD"CZ^Y]ZBT/28-!T*RTJV $5K"L8(&-Q
M'5C[DY)^M:%<U>M*K+R-*<%%!7->+/ NB>,+-H[^V5+K;B.[C4"5#VY[CV/%
M=+16,9.+NBVDU9GQKXG\.7OA37[C2;X?O(CE) /ED0]&'L?T.1VKWGX*^,9-
M>\/R:/>RE[W3@ C,>7A/W?J5/'TVUG?'[18YM#T[6D0>?;S_ &=V'=&!(S]"
MO_CQKS;X2ZJVE?$?3#N(CNBUK(!W#CC_ ,>"G\*]27[^AS/='*OW=2Q]5U\R
M?&__ )*/-_U[1?R-?3=?,GQO_P"2CS?]>T7\C7-@OXOR-:_PG$Z%HMYXBUNU
MTFQ0-<7+[5ST4=2Q]@ 2?I7U;X2\$:-X.L$AL+=6N2N)KMU'F2'OSV'L.*\B
M_9^TU)]>U;4F7+6MND2'T,A)S^2?J:^@:K&U6Y<BV0J$%;F"O'_BW\-;&YTF
MY\1Z/;);WEJIDN8HEPLR#[S8'1@.<]P#WKV"HYX8[FWD@E4-'(A1U/<$8(KE
MIU'3ES(UE%25F?$D4TD$JRPR-'(ARKH<$'V-=Y\+?A^/&>K23WNY=)LR#-MX
M,K'H@/;U)'0?4&N#FC\F>2+.=C%<^N#7U%\&[".R^&NGR*!ONGDGD([G>5'_
M (ZJUZN*J.G3NMV<E*/-+4[33].LM*LTL]/M8;:W3[L<2!0/R[^]27%M!>6[
MV]S#'-#(,/'(H96'H0:EHKQ[N]SM/F/XM^ X/".L0WFFH5TN^SLCR3Y,@ZK]
M#G(_$=J@^#FNR:/\0+2WWD6^H VTJYX)/*'Z[@!^)KUSXWVL=Q\.9I7 W6US
M%(G'<G;_ "8U\]^%7:/Q?HCJ<,M_ 0?0^8M>K1DZM!J1QS7)4T/LNLKQ)KUK
MX9\/W>KWA_=VZ9" X+L>%4>Y.*U:\-_:!UM]^DZ$C$+M-W*,]>2J?R>O.HT_
M:343IG+EC<\AU[7+[Q'K-QJFHR^9<3MD^B#LJCL .*]3^&WP?34[6'6_$J.+
M:0![>R!*F1>S.>H![ =?Y\7\,?#*>*?&]I:W";[.W!N;A<<,BXPI]BQ4'V)K
MZQ  & , 5W8JNZ:5.&AA2AS>](K6.G66EVRVUA:06L"](X8PB_D*LT45YE[G
M4<?XL^&OA[Q9!(TUHEI?'E;RW0*^?]H=''U_ BOF?Q1X7U'PEK4FF:E'AA\T
M<J_<E3LRGT_E7V17G_Q?\+Q^(/!5Q=(@^VZ:IN8FQR4 ^=?H5&?JHKLPV(E&
M2C+8QJTTU=;G%_!#QS()QX3U"4LC O8NQ^Z1RT?TZD?C[5[I7Q-I]]/IFHVU
M_:OLGMI5EC;T93D5]H:?>QZEIEK?0_ZJYA29/]U@"/YT\;249<RZBH2NK,\7
M_:(_YEO_ +>O_:5>(PPRW,\<$*-)+(P1$49+,3@ 5[=^T1_S+?\ V]?^TJXG
MX/Z='J'Q)T[S0&2W#W&#ZJIV_D2#^%=6'ERX=2[7,JBO4L>U?#_X::;X2L(;
MFZ@CN=:90TL[@-Y1_NIZ8]>I^G%=[117E3G*;O(ZU%15D<)\0_AOIWBW2Y[B
MVMHX-:C4M#.@"^:1_ _J#TR>1^8/RRRM&Y5E*NIP01@@U]PU\@_$&VCM/B#K
ML,2A4^V.P Z#<=Q_G7H8&HW>#.>O%+4D\&>%[SQWXL6S:>3:Y,]Y<L=S*N>3
MD]6).![FOJ;0O#ND^&K!;/2;**WB ^8J/F<^K-U)^M>8?L^Z>B:#J^I;1YDU
MTL&?0(H;_P!J5['6&+JN4^7HBZ,4HW$90RE6 *D8((ZUX-\9OAY9:7;+XDT>
MW6WB,@2\@C&$4MT<#MSP0/4>]>]5S_CJS6_\!Z[;NH;-C*Z@_P!Y5++^H%94
M*CA--%U(J43Y6\)ZY)X<\5:=JJ,0L$RF4#^*,\./Q4FOLD$$9!R#7P[7VEH,
MQN/#NF3G.9+2)SGKR@-=>/BO=D8X=[HO22)%$\DC!412S,3P .IKY!\;^*)O
M%WBJ[U-R?(+>7;(?X(A]T?4]3[DU]'?%34VTKX;ZO+&VV2:,6Z\]=[!3_P".
MEJ^6])T^35M9L=-B.)+N=(5/H68#/ZT8&"2<V%>6JB>M_!SX<0:C&OB;6H!)
M;AB+*W<95R#S(P[@'( ]B?2O>Z@LK.#3[&WLK9 D%O&L4:CLJC %3UQUJKJ2
MYF;0@HJP4445D607EG;:A9RVEY!'/;S+MDBD7*L/<5\O?$WP"W@K65>UW/I5
MV2UN[')0CJA/J.Q[CZ&OJBN1^)FA1Z_X!U. INFMXC=0''(= 3Q]1E?QKHPU
M9TY^3,ZL%*)\EU]C>"_^1$\/?]@RV_\ 12U\<U]C>"_^1$\/?]@RV_\ 12UU
MX_X48X?=FY7RY\:/^2FZA_URA_\ 1:U]1U\N?&C_ )*;J'_7*'_T6M88'^)\
MC2O\)P:O*T8@5G*,V1&#P6Z9QZU] ?#SX.65C:0ZIXFMUN;YP'2SDYCA';</
MXF]CP/?K7"?!7PY'K?C7[9<('M]-C\_!Z&0G"?U;_@-?35;8RNXODB11II^\
MQD44<$2Q0QI'&@PJ(N H] !1-#%<PM#/$DL3C#(ZAE8>X-/HKS3I/%OB1\';
M5[.?6?#%OY,\8+S6$8^60=S&.Q'/R]#VP>OAEI=7%C=PW=K*\-Q"X>.1#@JP
MY!%?;E?+/Q=\.1^'O'5P;>,):7R"ZB4#A220X_[Z!./0BO2PE=R]R1RUJ:7O
M(^@O GBE/%_A.UU3Y5N/]5<HO\$J]?P/!'L117D'P&U]+'5=5TRYF"6\T"W"
M[CP&5@I_,./^^:*Y*]+DJ-+8VISYHW9ZMXV\+-K=LMW9J/MT"XV_\]%ZX^OI
M^->2NCQNR2*R.IPRL,$'T-?0]8VL^%M*UP[[J#;/C FB.U_Q['\0:]++\T]A
M'V=76/Y$5*7,[H\/HKT6;X7#=F#52%])(<G\P?Z59L_AC91N&O+^:<#^&-!&
M#^IKUWFV$2OS?@S'V,^QP&D:/>:W?+:V<99CR[G[J#U)KVO1])M]%TV.RMA\
MJC+,1R[=R:EL-.L]+MA;V5ND,8YPHZGU)ZD_6K5>#C\PEBGRK2*_K4Z*=-0]
M0HHHKS34*JZAIMGJEJUM>P)+&>S#D'U![&K5%.,G%W6C#<\:\5>$Y_#TXEC+
M36,APDA'*G^ZWO[]ZP+:XEM+J*Y@<I+$P=&'8BO?;VS@U"REM+E \,J[64_Y
MZUXKXB\/77A^^,4H+V[']S-CAQ_0^U?4Y;CUB(^RJ_%^9R5:?*[K8]7\.>([
M;Q#8B2,A+E!^^ASRI]1ZCWJ[J>D:=K-K]FU.QM[N'KLFC# 'U&>A]Q7A-K=7
M%E<+<6TSQ2H?E=#@BNST_P")E] BI?6D=SCC>C>6Q^O!'\JXL5D]2,N;#ZKM
MU1<*R:M(Z6V^&?@RTN%GB\/6A=>GF;I%_P"^6)'Z5U2JJ(J(H55&  , "N!?
MXHVX3]WI<K-Z-* /SP:YO6/'6KZJC0HZVD#<%(>I'NW7\L5SPRO%U9>_HO-E
M>UA'8[37/B!9:3>&UMH#>R)Q(5DVJI],X.36KX<\26OB.U>2%&BFB($D3')7
M/0@]Q7B%>G?#C1;JSAN-1N4,:W"JL2L,%EZ[OITQ77CLOP^'PW,OB[]_D13J
M2E+R.[HHHKY\Z0HHHH **** "BBB@ KYD^-]BUI\1IK@C O+:*8'UP-G_LE?
M3=>0?'OP^UWH5EKL*9:QD,4Y'_/-\8)^C #_ (%73A)\M5>9E65X',_ #4UM
M_$VI::S8^UVPD7GJT;=/R=C^!KZ%KXT\,:[+X:\2V&KP@DVTH9E!QO0\,OXJ
M2*^P["^MM3T^WOK.59;>XC$D;KW!K3&P:GS=R:$KQL6****XC<**** "BBB@
M KY \?\ _)0=?_Z_I?\ T(U]?U\@>/\ _DH.O_\ 7]+_ .A&N[ ?&SGQ&R/<
M?@1_R3Z3_K^D_P#04KTZO,?@1_R3Z3_K^D_]!2O3JY\1_%D:T_@04445B6?%
M>M?\AW4/^OF3_P!"-?3?P?\ ^25Z-_VW_P#1\E?,FM?\AW4/^OF3_P!"-?3?
MP?\ ^25Z-_VW_P#1\E>IC?X2]?T.2A\;,CX\S&+P! @SB74(T//^P[?^RU\X
MP3RVMQ%<0.4EB<.CCJK Y!_.OI;XX6;77PYDE"Y^RW44QXZ Y3_V>OGSPI<0
M6GB[1Y[I4:W2]B,H<9&S>,\?3-5@W^Y"M\9I_P#"RO&?_0Q7O_?0_P */^%E
M>,_^ABO?^^A_A7U5_8NE?] RR_\  =?\*/[%TK_H&67_ (#K_A6'UNG_ "%^
MQE_,?*O_  LKQG_T,5[_ -]#_"C_ (65XS_Z&*]_[Z'^%?57]BZ5_P! RR_\
M!U_PH_L72O\ H&67_@.O^%'UNG_('L9?S'R1JOC/Q'K=D;+4]7N;JV+!C'(1
MC(Z&H?"CM'XPT213AEOX&'U$BU]>_P!BZ5_T#++_ ,!U_P *5='TQ'5TTZT5
ME.0P@4$'\J?UV*5E$/8.]VR[7S)\;_\ DH\W_7M%_(U]-U\R?&__ )*/-_U[
M1?R-9X+^+\BJ_P )U7[._P#S,G_;K_[5KW&O#OV=_P#F9/\ MU_]JU[C6>+_
M (S_ *Z%4?@04445SFA\27O_ !_W'_75OYU]5?"K_DF6B?\ 7)__ $8U?*M[
M_P ?]Q_UU;^=?57PJ_Y)EHG_ %R?_P!&-7J8[^&O4Y*'Q,[&BBBO+.L\_P#C
M1_R3+4/^NL/_ *,6OG+PQ_R-FC?]?T'_ *&M?1OQH_Y)EJ'_ %UA_P#1BU\Y
M>&/^1LT;_K^@_P#0UKU,'_!9R5OC1]FU\Q?&V8R_$FY0YQ%;Q(/^^=W_ +-7
MT[7S9\=K)K?Q['<[?DNK.-@?<%E(_0?G7-@OXOR-:_P&[^SQ;HUWX@N2/WD:
M01@^S%R?_017NU?/?[/^I+!XDU33F8 W5LLB@G[QC;I^3D_A7T)4XQ/VS'1^
M ****YC4*CN($N;:6WE&8Y4*,/8C!J2LWQ!J::-X=U'4G8*+:W>0$]R <#\3
M@4TFW9 SXOKZX^&TK3?#C068DD6H7D8X!('\J^1Z^P_ ]D^G>!=#M9 1(EG&
M7![$KDC\S7IX_P"!'+A]V>6_M$?\RW_V]?\ M*N<^!'_ "4&3_KQD_\ 0DKH
M_P!HC_F6_P#MZ_\ :5<Y\"/^2@R?]>,G_H24H?[I]_YA+^,?2E%%%>8=05\C
M_$K_ )*/KO\ U]'^0KZXKY'^)7_)1]=_Z^C_ "%=V!^-^AAB/A1['\ ?^1$O
MO^PG)_Z*BKU6O*O@#_R(E]_V$Y/_ $5%7JM<^(_BR-*?P(*RO$__ "*>L_\
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M_$'C &"YF6VL,Y%I;Y"G_>/5OQX]A6M\-OAQ/XB=]9U.%DT>W5F0.,?:7 X
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M)Y);MIPT.< %$7'('/RFNRHHJ92<I<S&DDK(*I:O9OJ.BW]C&RJ]S;R0JS=
M64@$_G5VBI3L,^>?^&?O$'_06TS\Y/\ XFO>=(LWT[1;"QD96>VMXX69>A*J
M 2/RJ[16M2O.I\1$81CL%%%%9%F%XE\'Z)XMM!!JUFLC*,1S)\LD?^ZW]#Q[
M5X]K?P U*%VDT/5(+F/J(KH&-Q[9&03^5>_45M3KU*?PLB5.,MSY8D^#GCI)
M"JZ*L@'1ENX<'\W!JU8_!+QI=N!/;6MD.[3W*MC_ +XW5].T5M]>J>1'L(GE
M/A?X&:-I4D=UK=PVJ3KR(=NR$'W'5OQ('J*]0DMU^Q/;0JL:^68T4# 48P!C
MTJ:BN:=2<W>3-(Q45H?//_#/WB#_ *"VF?G)_P#$U[KH&GR:3X<TO39G5Y+2
MTB@=DZ,40*2/;BM&BKJ5YU%:0HTXQV"O'O'WPCU?Q9XNN=8M-0L8894C4)+O
MW#:H!Z CM7L-%33J2IN\1RBI*S.$^&7@6]\$Z9J%K?W-M<&YE5QY.<  8P<@
M5A^+_@AI>L327NA3KIER^2T!7,#'V Y3\,CVKU>BFJ]13YT]1>SC:Q\M7WP:
M\;6;D)ID=T@_C@N$(/X,0?TJ.U^#_CBY?!T<0KG!>:XC 'X;L_I7U316_P!>
MJ6V1G[")XCX;^ 2I*D_B34ED4')M;/.&]BY /X ?C7LFG:;9:1816.GVL5M:
MQ#"1QK@#_$^_>K5%85*TZGQ,UC",=@HHHK(H**** "BBB@ KS'XGQ,-4L93]
MUH"H^H;G^8KTZN6\>:,VJZ"985+7%H3(H Y9?XA_7\*[LMJJEB8REMM]YG55
MX,\?HHHK[0X0HHHH *4 L<*"2>@%;'AKP_-XAU+R%)C@0;II<?='H/<U[!I>
MB:?H\ BLK9(^,%\9=OJ>M>;C<RIX9\MKR[&L*3GJ>%RVMQ"NZ6"6-?5T(J*O
MH>2-)HVCE171AAE89!'N*\Z\1?#N4SO<Z+L*,<FV9L%3_LD\8]C6&%SBG5ER
MU%R_D5.@UJM3SVMKPE!)<>*M.6,9*S!S[!>3_*IH?!/B&:79_9[)SRSNH _7
M^5>B>%/"<7AZ)II76:]D7#N!PH_NK_C6V.Q]&G2:C)-M=":=.3EJ=+1117R!
MVA7QUXULIM/\;ZW;3J5=;V5N>ZLQ93^((/XU]BUYU\2?A?#XSVZA8S1VNK1I
MLW.#LF4= V.01V//IZ8ZL+55.?O;,RK0<EH?,5%=I-\)_&\-SY']A2.2<!TE
MC*G\=W'XXKT3X??!>?3]1AU?Q,8B\+!X;)&WC<.A<]#CT&1ZGM7HSQ%.,;W.
M:-.3=K'J7A2RFTWPAHUE<9\^"RACD!/1@@!'X'BMBBBO%;N[G<M$%%%%( HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6UC:QVMI!%!;Q#:D42!54>P'2NBMC%*/+#J9PHM.[)J***\XZ0HHHH ****
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'HHHK(H__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140532524983360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  01,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Chemomab Therapeutics Ltd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Kiryat Atidim, Building 7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel Aviv<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6158002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">77-331-0156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember', window );">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CMMB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember', window );">Ordinary shares, no par value per share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, no par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>zk2329839_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cmmb="http://chemomab.com/20230601"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cmmb-20230601.xsd" xlink:type="simple"/>
    <context id="c20230601to20230601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <context id="c20230601to20230601_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <context id="c20230601to20230601_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20230601to20230601"
      id="Fact_c4648d413a80429490b83737684960a3">false</dei:AmendmentFlag>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20230601to20230601"
      id="Fact_827b499388894d2983d2699b4fac3458">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityCentralIndexKey
      contextRef="c20230601to20230601"
      id="Fact_bb5eac91d82c47d694f161e9a8eda0ed">0001534248</dei:EntityCentralIndexKey>
    <dei:SecurityExchangeName
      contextRef="c20230601to20230601_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"
      id="Fact_7800ee96276548b596341b580ba682e4">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="c20230601to20230601_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"
      id="Fact_6d5d9dde38ce41a79ef18960f5e679b6">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20230601to20230601"
      id="Fact_1e8d67a5e319479a96041d8c4f7e3915">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20230601to20230601"
      id="Fact_097c3bd6996d46e2bd4575c8433d9ffd">2023-06-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20230601to20230601"
      id="Fact_54f7699f403b4b8da0f3061dbb621ab8">Chemomab Therapeutics Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20230601to20230601"
      id="Fact_ed7f83e55f0a4b08beddae26671ea988">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20230601to20230601"
      id="Fact_23f534d54203453daaea000a94b759db">001-38807</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20230601to20230601"
      id="Fact_e24b9d3f80794d4685c212a8f19bc425">Kiryat Atidim, Building 7</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20230601to20230601"
      id="Fact_4fa2b9620e824a57b1f54dd90922a682">Tel Aviv</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="c20230601to20230601"
      id="Fact_b9d79dd8c8ac402da729318d023d8bec">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="c20230601to20230601"
      id="Fact_7d3c117f227b4ad7b829a6bd78c06980">6158002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20230601to20230601"
      id="Fact_056db533a90749b29f8b400205334538">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20230601to20230601"
      id="Fact_a465d30b3ba54a55af9eec32f997a7b4">77-331-0156</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20230601to20230601"
      id="Fact_58591e2e1f2443529562a6b7d3838234">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20230601to20230601"
      id="Fact_34813f63dc0844ef81c013044741f24c">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20230601to20230601"
      id="Fact_c93b00f1407c48d2abcfa1faa8eb2967">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20230601to20230601"
      id="Fact_ee53ffb1d4404dd9bf8384d2237b75eb">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20230601to20230601_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"
      id="Fact_b123c56576e3485d98bde4754511ff63">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20230601to20230601_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"
      id="Fact_efc8b1a62843452ea835025b22e31abb">CMMB</dei:TradingSymbol>
    <dei:Security12bTitle
      contextRef="c20230601to20230601_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"
      id="Fact_adcba5d2ba7c41fa96ede1c9ee9b9160">Ordinary shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20230601to20230601_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"
      id="Fact_e57ed6f5b2144c9b95a26c319b8d02b2">N/A</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20230601to20230601"
      id="Fact_dd30d57e27ef4063b7ff9d2b9c5d7da4">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="c20230601to20230601"
      id="Fact_4060debb196f400b9b60e23eaa2c782f">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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ML41N!H[OO%YXXNO8V ONL)_1-9LS\WLV4W#F'E0BGC*AN11$L=7 &?F75\W
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MU\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U .EK
M>MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ
M!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.
M\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    (  DXQ58'04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ "3C%5MB_>8WN    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ "3C%5IE<G",0!@  G"<  !,
M     ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  ).,56
M"+I!8 $%  !K%@  &               @($-"   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ "3C%5I^@&_"Q @  X@P   T
M     ( !1 T  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  ).,56EXJ[',
M   3 @  "P              @ $@$   7W)E;',O+G)E;'-02P$"% ,4
M"  ).,56'#AEZC\!   \ @  #P              @ $)$0  >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ "3C%5B0>FZ*M    ^ $  !H
M ( !=1(  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
M"3C%5F60>9(9 0  SP,  !,              ( !6A,  %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&      D "0 ^ @  I!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="zk2329839.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://chemomab.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:SecurityExchangeName -  zk2329839.htm 11</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="zk2329839.htm">zk2329839.htm</File>
    <File>cmmb-20230601.xsd</File>
    <File>cmmb-20230601_def.xml</File>
    <File>cmmb-20230601_lab.xml</File>
    <File>cmmb-20230601_pre.xml</File>
    <File>exhibit_99-1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image00001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "zk2329839.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 26
   },
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "cmmb-20230601_def.xml"
     ]
    },
    "inline": {
     "local": [
      "zk2329839.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cmmb-20230601_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cmmb-20230601_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cmmb-20230601.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 36,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 5
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "cmmb",
   "nsuri": "http://chemomab.com/20230601",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329839.htm",
      "contextRef": "c20230601to20230601",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://chemomab.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329839.htm",
      "contextRef": "c20230601to20230601",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share [Member]"
       }
      }
     },
     "localname": "AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember",
     "nsuri": "http://chemomab.com/20230601",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_OrdinarySharesNoParValuePerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares, no par value per share [Member]"
       }
      }
     },
     "localname": "OrdinarySharesNoParValuePerShareMember",
     "nsuri": "http://chemomab.com/20230601",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityListingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Listings [Line Items]"
       }
      }
     },
     "localname": "EntityListingsLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container for exchange listing information for an entity",
        "label": "Entity Listings [Table]"
       }
      }
     },
     "localname": "EntityListingsTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001178913-23-002136-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-23-002136-xbrl.zip
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MXKK>LU?\[^[E34'V=^HF_P-02P,$%     @ "3C%5M;'1YDY!P  GE   !4
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M"'"9M.2+K-PTM6W<0T$GU=:YN*/[V#P@ROC6A$[!["6?L;L%B-AI+>)4U^>
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MXR"-,/( W6= N>7"="S-V_;@F\ L53]2I+WY%^$!T'U45$V.K+N_+"7YTW1
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MN!F(9/6Z??7R";71^47XS4G_#U!+ P04    "  ).,56ZN/'JQX"  ##?@
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M9/3S%$N4B.&10-L6!P
M                 (#_HB32]PU02P,$%     @ "3C%5B*'VM?W(0  ^?0
M  T   !Z:S(S,CDX,SDN:'1M[3UK<^.XD=^OZOX#HMPFGIPD\RF)'H^K_)H=
M9\>/L[V;O?N2 DE0X@Y%*B1E6_GUUPV %"F1EFQ+MCPC)[5#D2#0:'0W^H7F
M_B =!N1A&(3)WH,=!_ZGQB!-1WN[N_?W]VV\TX[B_JZF*/JN'R8I#1W6D.T#
M/_SV2'-\;-,D;_XPU_Y>YZU5R[)V^=.\:>)7-81NU=W?S[_>. ,VI*U9>'!X
M=_IB$9K.KGB8-?63R-#4[F.3%2VR%Y(XS1M[-+%Y0[@)C34M[_6AKD,5L0<S
M9+\?77^=-D^KVT^;[J8Q#1,OBH<T]:,01U-:BM92"V.FK80YI8[@=[L?W3W:
MCVJVE%Y+5[-^QDFK3^EH?I+R06FB+IM!<S8B/"@U=*)QF,:3ZL;R8?F%<1RS
MT*E[0SXM Y/&K70R8DDU,N'Q+CZ6N%-;VG3.:5Q+ =8N/,T:AM1WDFJ0^*,2
M/(GO5#>%!^6&Z2BN:0E/2DW9@S.H;HI/RAAD7@WRF%=N.!S:>4ODJ&A([;83
M#;&5KG24#$_U/(O"HW'PG_]!R/Z 49=?P77JIP$[V-\5_\J;?VJUR%??86'"
M7))&>^3_6K^0G[]>'AU^%2WXWTGDC(<L3(D3,YI"RW'BAWUR%$?4C7VWS\C5
M]:7G!XQH>EN%_YFJ:A;>/XY&D]CO#U("$)JD17 NQ==;K0R@(4LIP9FUV+_&
M_MVGQG$4IC!TZQ:HI4$<\>M3(V4/Z2Z?*=F%=_=WY53ATH[<"4G22< ^-3QH
MW_+HT \F>^2OM_Z0)>2"W9-K0&OXUR;A=YHD8;'O?22\=>+_F^T151FE'PF.
MTJ*!WP_W2, \N.-$013OD3\K_.\CL:GSK1\#S[BM[)''_S[B$NR[_AWQW4^-
MDYNKSS[R_!??=5G8R.!S_6044( MC$(&K^S[#WLX$Q:+2]Z:7T*#"UB$V'=(
M2(?X*O/W#F%57%R9SP'M-_A(GZF3_M,Q.D;/-52=]A1#LPQ+L7MZ5^]V>H;5
M4:@N$?F07B-=.AEII=&4R(18^M0 4;;G^0_,!30&L&\<\'_V=TL@U4-X&@*]
M36[IPQE,)/4]W^&R#AK:+"Y W-.ZMF%9>J_7LPQ7LWJZJW4LRS8\ZNB&V5L,
M\8$"@D3\/1&Z8X LIL%9Z+*'7]BD )5MFXPZENKV-,?HNAW+\-2.RBS:8RY5
MF+L45"#5=4,S>DM#=<- I )<IR!%:-AG%_"D %2WIRB,61VMVS&-GFU:'=U0
M;;.GV+33TYBQ$*A_WJ3 Q4@VQP%-DDOO)HV<;X</?O+/R]CU0QI/;@8T9LE%
M=$7CWV@P9E<LYK?.&5^W@XO#FY/#_UG5C#JNZ5I Z7K/889*NQ;SU!X0JF>R
M3M>R.R^9T2&'A88G;!0E?IK/[90Z@VLV@BNDR[!_>P__3C3EA1C8+7-MS#R&
MFR-+#O91E]I+N)8$\R!<M]H;Q'Q*(/5;V63:#PD0EGB,>^2G1N(/1P&PWOYN
MN0\Q7'$,_C.)QC'_Q77'/8D[CNY*$I7M&&>&[)<O^97%A(_'*I69X[-?RB0^
M^_)!=JO<^PBP%;G9+] 8X_0$5O  @6HI'= (LO>FSW(PW9JFV9/L=S;(;@D/
M2Z+E#4AJO>L@T<GZ."?QTX7!'D:![_BI@(&XL!^&"0CH3PVI8N[5XJ%Q@&2[
MMQYL[.]6 I@O9CZ/[X^\OF]R^>Z7?[<L@W<+&MTNJ(-<1P5%%R_WDQ$-EU15
MA:9:HZ@V#LC^+G8V/X;4JP=Q-HX=Q0",U#B)^-6RHS2-AM#;Z($D4>"[Q Y
ML\V?I]%HCQBS#P<,E7H.P\-4-9;Z[R.J<4FO!N,C9?%',J1QWP];J&;O$3I.
MH_Q6+$;A]X2ZSZ>$LY-XM&.X79PZ;S JHE9@:A%BY8A\NMP"D#<R_,Q9!1)Z
MX$;[@/QZ<79[>D)N;@]O3V_V=VT :710"XZQ9G!N3H]_O3Z[/3N](8<7)^3T
M]^,OAQ<_GY+CR_/SLYN;L\N+A2"N&V/_.+SY<G;Q\^WE19.<M(_;8!B:AO5:
M8#4._O)GM:-\%/]]T[7Z?'E]3FK5Y\S^%C9PKC:KK.=VNM1DNFH978N"QFR
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M-90&_SVBKIO]%OHOOYP#8S=$1@K(##"Y5_E&0'/ON^D WU!^RO5I4(@#.DI
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MR_@+K>X<G[5JP?@: ?5<X43FC']J=$Q75VS=IB;(?)-Z%F..KGF6U:4@"98
MI=MMZ;K:4E2SLS[O\1L2QLYGV"[ OA4.SICO'O"3"L8'FO"("(L $P-],!+0
M)(L!O)Z;<R7]'@^8\XU'?>AH%$<@T-#"MZ,'8K,@NL>IXD-$B "AU_J%>'Z
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M69]E#J&"),#,*5!#$S#1\B*1CBE-F^/,B*-$?&<F%7H;.3L[(T-1A5HVY5,
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M4$L! A0#%     @ "3C%5M;'1YDY!P  GE   !4              ( !-Q8
M &-M;6(M,C R,S V,#%?<')E+GAM;%!+ 0(4 Q0    (  DXQ5::EE?LF1(
M $))   0              "  :,=  !E>&AI8FET7SDY+3$N:'1M4$L! A0#
M%     @ "3C%5NKCQZL> @  PWX   X              ( !:C   &EM86=E
M,# P,#$N:G!G4$L! A0#%     @ "3C%5B*'VM?W(0  ^?0   T
M     ( !M#(  'IK,C,R.3@S.2YH=&U02P4&      < !P"] 0  UE0

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
